Literature DB >> 27500119

Comment on roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy.

Abdullah Ilhan1, Umit Yolcu1, Uzeyir Erdem2.   

Abstract

Entities:  

Year:  2016        PMID： 27500119      PMCID： PMC4951665          DOI： 10.18240/ijo.2016.07.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  5 in total

1.  Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier.

Authors:  Stephen J Giebel; Gina Menicucci; Paul G McGuire; Arup Das
Journal:  Lab Invest       Date:  2005-05       Impact factor: 5.662

2.  Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy.

Authors:  Shu-Ling Wu; Dong-Mei Zhan; Shu-Hong Xi; Xiang-Lian He
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.

Authors:  Toshihisa Sumii; Eng H Lo
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

4.  Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.

Authors:  Denise M Boudreau; Gregory F Guzauskas; Er Chen; Deepa Lalla; Darren Tayama; Susan C Fagan; David L Veenstra
Journal:  Stroke       Date:  2014-09-04       Impact factor: 7.914

5.  Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.

Authors:  G E Davis; K A Pintar Allen; R Salazar; S A Maxwell
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.